384 related articles for article (PubMed ID: 11685488)
41. Benzodiazepine receptors in chronic cerebrovascular disease: comparison with blood flow and metabolism.
Sasaki M; Ichiya Y; Kuwabara Y; Yoshida T; Fukumura T; Masuda K
J Nucl Med; 1997 Nov; 38(11):1693-8. PubMed ID: 9374335
[TBL] [Abstract][Full Text] [Related]
42. Quantitation of benzodiazepine receptor binding with PET [11C]iomazenil and SPECT [123I]iomazenil: preliminary results of a direct comparison in healthy human subjects.
Bremner JD; Baldwin R; Horti A; Staib LH; Ng CK; Tan PZ; Zea-Ponce Y; Zoghbi S; Seibyl JP; Soufer R; Charney DS; Innis RB
Psychiatry Res; 1999 Aug; 91(2):79-91. PubMed ID: 10515463
[TBL] [Abstract][Full Text] [Related]
43. Modeling alternatives for cerebral carbon-11-iomazenil kinetics.
Buck A; Westera G; vonSchulthess GK; Burger C
J Nucl Med; 1996 Apr; 37(4):699-705. PubMed ID: 8691270
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of the reference tissue models for PET and SPECT benzodiazepine binding parameters.
Millet P; Graf C; Buck A; Walder B; Ibáñez V
Neuroimage; 2002 Oct; 17(2):928-42. PubMed ID: 12377167
[TBL] [Abstract][Full Text] [Related]
45. Positron emission tomography receptor studies.
Duncan JS
Adv Neurol; 1999; 79():893-9. PubMed ID: 10514872
[TBL] [Abstract][Full Text] [Related]
46. [Benzodiazepine receptor imaging with positron emission tomography and single photon emission tomography].
Bartenstein P; Koepp M
Nervenarzt; 1995 Jun; 66(6):412-21. PubMed ID: 7637827
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and PET imaging of the benzodiazepine receptor tracer [N-methyl-11C]iomazenil.
Baldwin RM; Horti AG; Bremner JD; Stratton MD; Dannals RF; Ravert HT; Zea-Ponce Y; Ng CK; Dey HM; Soufer R
Nucl Med Biol; 1995 Jul; 22(5):659-65. PubMed ID: 7581177
[TBL] [Abstract][Full Text] [Related]
48. Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: an 11C-flumazenil PET study.
Richardson MP; Koepp MJ; Brooks DJ; Fish DR; Duncan JS
Ann Neurol; 1996 Aug; 40(2):188-98. PubMed ID: 8773600
[TBL] [Abstract][Full Text] [Related]
49. Parametric images of benzodiazepine receptor concentration using a partial-saturation injection.
Delforge J; Spelle L; Bendriem B; Samson Y; Syrota A
J Cereb Blood Flow Metab; 1997 Mar; 17(3):343-55. PubMed ID: 9119907
[TBL] [Abstract][Full Text] [Related]
50. Different sensitivities to competitive inhibition of benzodiazepine receptor binding of 11C-iomazenil and 11C-flumazenil in rhesus monkey brain.
Inoue O; Hosoi R; Kobayashi K; Itoh T; Gee A; Suzuki K
Ann Nucl Med; 2001 Apr; 15(2):137-9. PubMed ID: 11448072
[TBL] [Abstract][Full Text] [Related]
51. Use of a standardized uptake value for parametric in vivo imaging of benzodiazepine receptor distribution on [11C]flumazenil brain PET.
Tsukamoto M; Katoh C; Shiga T; Kaji T; Kuge Y; Nakada K; Tamaki N
Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):846-51. PubMed ID: 14985864
[TBL] [Abstract][Full Text] [Related]
52. Quantitative estimation of I-123-Iomazenil receptor binding in temporal lobe epilepsies using two SPECT acquisitions--comparison with the regional cerebral blood flow and a compartment model.
Venz S; Hierholzer J; Cordes M; Straub HB; Keske U; Meencke HJ; Eichstädt H; Felix R
Nuklearmedizin; 1998 Mar; 37(2):49-56. PubMed ID: 9547750
[TBL] [Abstract][Full Text] [Related]
53. Reduced GABAA benzodiazepine receptor binding in veterans with post-traumatic stress disorder.
Geuze E; van Berckel BN; Lammertsma AA; Boellaard R; de Kloet CS; Vermetten E; Westenberg HG
Mol Psychiatry; 2008 Jan; 13(1):74-83, 3. PubMed ID: 17667960
[TBL] [Abstract][Full Text] [Related]
54. Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography.
Koeppe RA; Holthoff VA; Frey KA; Kilbourn MR; Kuhl DE
J Cereb Blood Flow Metab; 1991 Sep; 11(5):735-44. PubMed ID: 1651944
[TBL] [Abstract][Full Text] [Related]
55. Development of a new radioligand, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide, for pet imaging of peripheral benzodiazepine receptor in primate brain.
Zhang MR; Maeda J; Ogawa M; Noguchi J; Ito T; Yoshida Y; Okauchi T; Obayashi S; Suhara T; Suzuki K
J Med Chem; 2004 Apr; 47(9):2228-35. PubMed ID: 15084121
[TBL] [Abstract][Full Text] [Related]
56. Novel fluorine-18 PET radiotracers based on flumazenil for GABAA imaging in the brain.
Rodnick ME; Hockley BG; Sherman P; Quesada C; Battle MR; Jackson A; Linder KE; Macholl S; Trigg WJ; Kilbourn MR; Scott PJ
Nucl Med Biol; 2013 Oct; 40(7):901-5. PubMed ID: 23890694
[TBL] [Abstract][Full Text] [Related]
57. Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors.
Wilson AA; Garcia A; Parkes J; McCormick P; Stephenson KA; Houle S; Vasdev N
Nucl Med Biol; 2008 Apr; 35(3):305-14. PubMed ID: 18355686
[TBL] [Abstract][Full Text] [Related]
58. Saturation analysis in PET--analysis of errors due to imperfect reference regions.
Litton JE; Hall H; Pauli S
J Cereb Blood Flow Metab; 1994 Mar; 14(2):358-61. PubMed ID: 8113332
[TBL] [Abstract][Full Text] [Related]
59. Quantitative in vivo analysis of benzodiazepine binding sites in the human brain using positron emission tomography.
Iyo M; Itoh T; Yamasaki T; Fukuda H; Inoue O; Shinotoh H; Suzuki K; Fukui S; Tateno Y
Neuropharmacology; 1991 Mar; 30(3):207-15. PubMed ID: 1649414
[TBL] [Abstract][Full Text] [Related]
60. Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil.
Abi-Dargham A; Krystal JH; Anjilvel S; Scanley BE; Zoghbi S; Baldwin RM; Rajeevan N; Ellis S; Petrakis IL; Seibyl JP; Charney DS; Laruelle M; Innis RB
Am J Psychiatry; 1998 Nov; 155(11):1550-5. PubMed ID: 9812116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
